11,452 Shares in Doximity, Inc. $DOCS Purchased by Strs Ohio

Strs Ohio bought a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 11,452 shares of the company's stock, valued at approximately $665,000.

A number of other institutional investors have also modified their holdings of DOCS. Amalgamated Bank increased its position in Doximity by 0.3% during the first quarter. Amalgamated Bank now owns 60,928 shares of the company's stock worth $3,536,000 after purchasing an additional 186 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Doximity by 0.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company's stock valued at $2,262,000 after purchasing an additional 210 shares during the period. Greenleaf Trust boosted its stake in shares of Doximity by 5.4% in the first quarter. Greenleaf Trust now owns 4,492 shares of the company's stock valued at $261,000 after purchasing an additional 230 shares during the period. Spire Wealth Management boosted its stake in shares of Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares during the period. Finally, Allworth Financial LP boosted its stake in shares of Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Price Performance

Shares of NASDAQ DOCS opened at $72.89 on Friday. The business's fifty day moving average price is $64.76 and its 200-day moving average price is $59.96. The stock has a market capitalization of $13.65 billion, a PE ratio of 72.89, a P/E/G ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a one year low of $40.15 and a one year high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period last year, the company posted $0.28 EPS. The company's quarterly revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current fiscal year.

Insider Transactions at Doximity

In other Doximity news, Director Timothy S. Cabral sold 10,000 shares of Doximity stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares in the company, valued at approximately $381,600. This trade represents a 61.12% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the company's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director owned 16,618 shares of the company's stock, valued at $948,721.62. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 37,000 shares of company stock worth $2,281,880. 31.30% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

DOCS has been the topic of a number of research analyst reports. Evercore ISI upgraded shares of Doximity from an "in-line" rating to an "outperform" rating and increased their price objective for the company from $50.00 to $70.00 in a research note on Wednesday, July 9th. JPMorgan Chase & Co. lowered their price objective on shares of Doximity from $63.00 to $60.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 27th. Piper Sandler raised their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Wells Fargo & Company raised their price objective on shares of Doximity from $55.00 to $62.00 and gave the company an "equal weight" rating in a research report on Monday, August 4th. Finally, KeyCorp boosted their target price on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a research report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $67.42.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.